Published

PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: International Journal of Gynecological Cancer
Date: 2024-09-30
Source: OpenAlex
DOI: 10.1136/ijgc-2024-igcs.54
PubMed: Unavailable

Authors

Daniel Spinosa Stacy M. Fischer Richard J. Zeifman Carolyn Lefkowits Petros Petridis Stephen Ross

Watch author

Topics and keywords

psilocybin Clinical Trial Randomized Controlled Trial Randomized Controlled Trial Double blind Psilocybin Placebo Randomized controlled trial Medicine Psychotherapist Psychology Internal medicine Psychiatry Hallucinogen Alternative medicine Pathology Psychedelics and Drug Studies Psychotherapy Techniques and Applications Chemical synthesis and alkaloids

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial2024-09-30

Related papers

Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical TrialAmerican Journal of Psychiatry · 2024-12-31 Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trialGeneral Hospital Psychiatry · 2025-08-11 Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26 Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionTrials · 2024-07-02 Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24 Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trialAddiction · 2025-07-23 Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04